Biochemical and Structural Characterization of OXA-405, an OXA-48 Variant with Extended-Spectrum β-Lactamase Activity by Oueslati, Saoussen et al.
HAL Id: hal-02456665
https://hal.archives-ouvertes.fr/hal-02456665
Submitted on 27 Jan 2020
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Biochemical and Structural Characterization of
OXA-405, an OXA-48 Variant with Extended-Spectrum
-Lactamase Activity
Saoussen Oueslati, Pascal Retailleau, Ludovic Marchini, Laurent Dortet,
Rémy Bonnin, Bogdan Iorga, Thierry Naas
To cite this version:
Saoussen Oueslati, Pascal Retailleau, Ludovic Marchini, Laurent Dortet, Rémy Bonnin, et al.. Bio-
chemical and Structural Characterization of OXA-405, an OXA-48 Variant with Extended-Spectrum
-Lactamase Activity. Microorganisms, MDPI, 2020, 8 (1), pp.24. ￿10.3390/microorganisms8010024￿.
￿hal-02456665￿
microorganisms
Article
Biochemical and Structural Characterization of
OXA-405, an OXA-48 Variant with
Extended-Spectrum β-Lactamase Activity
Saoussen Oueslati 1, Pascal Retailleau 2, Ludovic Marchini 2, Laurent Dortet 1,3,4,
Rémy A. Bonnin 1,3 , Bogdan I. Iorga 2 and Thierry Naas 1,3,4,*
1 EA7361 “Structure, dynamic, function and expression of broad spectrum β-lactamases”, Faculty of Medicine
of Paris-Sud University, Labex LERMIT, University Paris-Saclay, 94270 Le Kremlin-Bicêtre, France;
oueslati.saoussen@gmail.com (S.O.); laurent.dortet@aphp.fr (L.D.); remy.bonnin@u-psud.fr (R.A.B.)
2 Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Labex LERMIT, 91198 Gif-sur-Yvettte, France;
pascal.retailleau@cnrs.fr (P.R.); ludovic.Marchini@vinci.fr (L.M.); bogdan.iorga@cnrs.fr (B.I.I.)
3 French National Reference Center for Antibiotic Resistance: Carbapenemase-producing Enterobacteriaceae,
94270 Le Kremlin-Bicêtre, France
4 Bacteriology-Hygiene unit, Bicêtre Hospital, Assistance Publique/Hôpitaux de Paris,
94270 Le Kremlin-Bicêtre, France
* Correspondence: thierry.naas@aphp.fr; Tel.: +33-1-45-21-20-19; Fax: +33-1-45-21-63-40
Received: 21 November 2019; Accepted: 18 December 2019; Published: 21 December 2019 
Abstract: OXA-48-producing Enterobacterales have now widely disseminated globally. A sign of
their extensive spread is the identification of an increasing number of OXA-48 variants. Among
them, three are particularly interesting, OXA-163, OXA-247 and OXA-405, since they have lost
carbapenem activities and gained expanded-spectrum cephalosporin hydrolytic activity subsequent
to a four amino-acid (AA) deletion in the β5–β6 loop. We investigated the mechanisms responsible
for substrate specificity of OXA-405. Kinetic parameters confirmed that OXA-405 has a hydrolytic
profile compatible with an ESBL (hydrolysis of expanded spectrum cephalosporins and susceptibility
to class A inhibitors). Molecular modeling techniques and 3D structure determination show that the
overall dimeric structure of OXA-405 is very similar to that of OXA-48, except for the β5–β6 loop,
which is shorter for OXA-405, suggesting that the length of the β5–β6 loop is critical for substrate
specificity. Covalent docking with selected substrates and molecular dynamics simulations evidenced
the structural changes induced by substrate binding, as well as the distribution of water molecules in
the active site and their role in substrate hydrolysis. All this data may represent the structural basis
for the design of new and efficient class D inhibitors.
Keywords: oxacillinase; OXA-ESBL; carbapenemase; substrate selectivity; beta-lactamase; crystal
structure; docking; antibiotic resistance
1. Introduction
The widespread use of antibiotics led to the emergence of carbapenem resistance in Gram-negative
bacteria and became a real clinical concern. This resistance is mostly due to the production of
carbapenem-hydrolyzing β-lactamases, carbapenemases that belong to Amber class A (KPC), B (NDM,
VIM, and IMP), or D (OXA-48 and its variants) [1]. One of the main carbapenemases is the class
D β-lactamase OXA-48, which represents a major public health threat because of its rapid spread
worldwide [2–4]. Although OXA-48 hydrolyzes penicillins at high level, it hydrolyzes carbapenems
at a low level and shows very weak activity against expanded-spectrum cephalosporins. However,
when associated to impaired outer-membrane permeability and an ESBL, OXA-48-producers may turn
Microorganisms 2020, 8, 24; doi:10.3390/microorganisms8010024 www.mdpi.com/journal/microorganisms
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into deadly bacteria, as only limited antibiotic choices are left for treating serious infections with these
bacteria [5].
The OXA-48 β-lactamase was initially identified from a Klebsiella pneumoniae isolate in Istanbul
(2004) [4]; it then rapidly spread throughout the Mediterranean area, the Middle East, and Europe [6]
and became an increasing threat. Since OXA-48’s first identification, several OXA-48 variants
have been reported worldwide [7,8]. All these enzymes, except OXA-163, OXA-247, and OXA-405,
have similar hydrolytic profiles as OXA-48: a high level of hydrolysis of penicillin, a low level
of carbapenem hydrolysis, but no significant hydrolysis of broad-spectrum cephalosporins, such
as ceftazidime [9]. OXA-163 (identified from K. pneumoniae and Enterobacter cloacae isolates in
Argentina and in Egypt) [10,11], OXA-247, a point mutant derivative of OXA-163 from Argentina [12],
OXA-439, another point mutant derivative of OXA-163 (unpublished, KP727573.1), and OXA-405
(identified from S. marcescens in France) [13] differ by a four amino-acid deletion (213-TRIE-217 for
OXA-405; 214-RIEP-217, plus a substitution S212D for OXA-163, Y124H, and S212D for OXA-439, and
YS211-212SN for OXA-247), located in the β5–β6 loop, which results in a modified β-lactam spectrum
of hydrolysis (Figure 1). Indeed, analysis of the hydrolytic properties of OXA-163 and OXA-405
showed an ESBL-type profile, that they hydrolyze cefotaxime and cephalothin efficiently, are partially
inhibited by clavulanate, and lack significant carbapenem hydrolysis [13]. The aim of this study was
to investigate the mechanisms responsible for this peculiar substrate specificity of OXA-405, using
biochemical and structural tools, and to compare the resulting structure and the hydrolytic profile with
those of OXA-163 and OXA-48.
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2. Materials and Methods
2.1. Bacterial Strains
The clinical strain S. marcescens expressing the OXA-405 β-lactamase was used for the cloning of
the blaOXA-405 gene [13]. E. coli TOP10 (Invitrogen, Saint-Aubin, France) was used for cloning, and E.
coli BL21 (DE3) (Novagen, Fontenay-sous-Bois, France) was used for overexpression experiments.
2.2. PCR, Cloning, Expression, and DNA Sequencing
Whole-cell DNA of S. marcescens [13] isolates producing OXA-405 was extracted, using the
QIAamp DNA mini kit (Qiagen, Courtaboeuf, France) and used as a template to amplify the blaOXA-405
gene. The sequences without the peptide signal (predicted by SignalIP 4.1 Server) of blaOXA-405 gene,
encoding for the mature protein from amino acid K23 to P261, were obtained by PCR amplification,
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using primers OXA23-256NdeI (5′-aaaaaCATATGaaggaatggcaagaaaacaaa-3′), which included an NdeI
restriction site and the reverse primer OXAXhoI-∆stop (5′-aaaaaCTCGAGggggaataatttttcctgtttgag-’3),
which included an XhoI restriction site and a deletion of the stop codon of the gene to allow the
expression of an C_Term His tag. Then, PCR product was cloned into pET41b vector (Invitrogen®, Life
Technologies, Cergy-Pontoise, France), using NdeI and XhoI restriction enzymes, to obtain a C-Term
His8-tag. The accuracy of the recombinant plasmid was verified by sequencing, using a T7 promoter
and T7 terminator with an ABI Prism 3100 automated sequencer (Applied Biosystems, Thermo Fisher
Scientific, Les Ulis, France). The nucleotide sequences were analyzed by using software available at
the National Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov).
2.3. Protein Purification
The recombinant plasmid pET41b-OXA-40523-265 HIS was transformed into E. coli BL21 (DE3), and
an overnight culture was used to inoculate 2 L of Luria Bertani medium broth containing 50 µg/mL of
kanamycin. Bacteria were cultured at 37 ◦C, until an OD of 0.6 at 600 nm was reached. The expression
of the β-lactamase genes was carried out at 37 ◦C for 3 h, with 1 mM of IPTG as an inducer. Cells were
pelleted by centrifugation, at 6000× g for 15 min, then resuspended with 25 mM of phosphate sodium
pH 7.4, 300 mM of K2SO4, and 10 mM of imidazole. Bacterial cells were disrupted by sonication, and
the bacteria debris was removed by 2 centrifugations: first at 10,000× g for 1 h at 4 ◦C, and then the
supernatants obtained were centrifuged at 96,000× g for 1 h at 4 ◦C. The soluble fraction was filtered
and then passed through a HisTrapTMHP column (GE Healthcare®, Velizy-Villacoublay, France). The
OXA-405His8 protein was eluted, using elution buffer (25 mM of phosphate sodium pH 7.4, 300 mM
of K2SO4, and 500 mM of imidazole). The eluted protein was concentrated by using Vivaspin 20 (10
000 MWCOPES Sartorius®, Aubagne, France) and then dialyzed against 0.1 M of HEPES (pH 7.5)
buffer. The protein purity, estimated by SDS–PAGE, was more than 99%, and the pooled fractions
were dialyzed against 10 mM of Tris-HCl pH 7.6 and concentrated, using Vivaspin columns. Protein
concentration was determined by Bradford Protein assay (Bio-Rad, Marnes-La-Coquette, France).
2.4. Steady State Kinetic Determinations
Purified β-lactamase was used for kinetic measurements, which were determined in 100 mM
of Tris-H2SO4 and 300 mM of K2SO4 (pH 7), and antibiotics were purchased from Sigma-Aldrich
(Saint-Quentin Fallavier, France) [9]. The kcat and Km values were determined by analyzing β-lactam
hydrolysis under initial-rate conditions, with an ULTROSPEC® 2000 model UV spectrophotometer (GE
Healthcare, Velizy-Villacoublay, France) and SWIFT II software (GE Healthcare, Velizy-Villacoublay,
France), using the Eadie–Hofstee linearization of the Michaelis–Menten equation. The concentration
that reduced the level of hydrolysis by 50% (IC50) was determined in a buffer comprising 100 mM
of Tris-H2SO4 and 300 mM of K2SO4 (pH 7), with 100 µM of benzylpenicillin as a reporter substrate.
The enzymes were incubated with different concentrations of inhibitors, for 3 min, before the kinetic
parameter determination [9].
2.5. Protein Crystallization and X-Ray Crystallography
Crystallization conditions using commercial kits (Classics, PEGs I and II, and AmSO4 suites from
Qiagen, Courtaboeuf, France) were screened in sitting-drop vapor diffusion experiments, using a
Cartesian nanodrop robot (Genomic Solutions, Ann Harbor, MI, USA) on the I2BC Crystallization
Platform (CNRS, Gif-sur-Yvette, France). OXA-405 at 33 mg/mL concentration was crystallized over a
reservoir containing 2.2 M of ammonium sulfate and 0.2 M of sodium fluoride. Crystals were transferred
to a cryoprotectant solution (mother liquor supplemented with 20% glycerol) and flash-frozen in
liquid nitrogen. Diffraction data were collected at 100 K, to a resolution of 2.26 Å, using a RIGAKU
MicroMax™ 007 HF rotating copper anode with OSMIC VariMaxHF mirrors and an MAR345 image
plate detector, at the Institut de Chimie des Substances Naturelles (CNRS, Gif-sur-Yvette, France).
Diffraction intensities were integrated with the program XDS [14].
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The dimer structure of OXA-405 was solved by molecular replacement with Molrep [15], using
the monomer moiety of the OXA-48 structure (Protein Data Bank code 3HBR [16]) as a search model.
Model refinement was performed with BUSTER-TNT [17]. Electron density maps were evaluated,
using COOT [18] for manual refinement. The maps revealed clear density for the carboxylated lysine-73
residues. In contrast, the side chain of the N-ter Met-22 residues, as well as the C-ter 6xHis-tag, was
unseen. Refinement details of the structure are shown in Table 3. Molecular graphics images were
generated using UCSF Chimera version 1.10.2 (https://www.cgl.ucsf.edu/chimera/) [19].
2.6. Structure Analysis, Docking, Molecular Dynamics, and Water Network Analysis
OXA-405 structural analysis and comparison with other crystal structures were performed with
UCSF Chimera package [19]. Covalent docking calculations were performed, using the GOLD software,
version 5.2 (CCDC suite) [20]. Ligand structures were generated with 3D Structure Generator CORINA
Classic (Molecular Networks GmbH, Nuremberg, Germany). Molecular dynamics simulations of
OXA-405 were performed with Gromacs version 4.6 [21], using the OPLS-AA force field [22]. HOP
software version 0.4.0 alpha 2 (https://github.com/Becksteinlab/hop) [23] was used for water molecule
dynamics analysis.
2.7. PDB Deposition
The crystallographic structure of OXA-405 was deposited into the Protein Data Bank (PDB) [24],
accession code 5FDH.
3. Results
3.1. Biochemical Properties of OXA-405
To confirm previous findings based only on specific activities [13], and to understand the structural
features explaining the differences observed with OXA-48, we purified OXA-405, determined the
3D structure, and determined the steady-state kinetic parameters for several clinically relevant
substrates (penicillin, cephalosporins, and carbapenems) and compared them to those of OXA-163
and OXA-48 (Table 1). For OXA-48, the highest catalytic efficiency was observed for amoxicillin
hydrolysis (2400 mM−1 s−1) (Table 2). As observed by others, carbapenems are among the preferred
OXA-48 substrates, with the highest catalytic efficiency (kcat/Km) observed for the hydrolysis of
imipenem (370 mM−1 s−1) [9,16]. Compared to imipenem, the OXA-48 kcat/Km value is 59-fold
smaller for meropenem and 284-fold smaller for ertapenem hydrolysis because of a reduction in
the turnover number (kcat). In addition, the early cephalosporin, cephalothin, is hydrolyzed with a
kcat/Km slightly higher than that of the oxyimino cephalosporin cefotaxime mainly because of a lower
Km value. Finally, the steady-state kinetic analysis indicates OXA-48 does not hydrolyze the bulky
oxyimino–cephalosporin ceftazidime, as previously suggested. The substrate profile of OXA-405 is
substantially different from that of OXA-48, but quite similar to that of OXA-163. Unlike OXA-48,
OXA-405 hydrolysis preferentially cephalosporins (Table 1). The highest kcat/Km values were observed
for benzylpenicillin (667 mM−1 s−1), ampicillin (137 mM−1 s−1), cephalothin (444 mM−1 s−1), and
cefotaxime (26 mM−1 s−1). Ceftazidime was hydrolyzed with the lowest kcat/Km (0.7 mM−1 s−1)
among the cephalosporins tested because of a high Km value. Nevertheless, OXA-405 does hydrolyze
ceftazidime. The carbapenemase activity of OXA-405 is attenuated largely because of a reduction in
the turnover number and of the affinity for carbapenems, except for ertapenem; the carbapenemase
activity was nevertheless higher for OXA-405 as compared to OXA-163.
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Table 1. Steady-state kinetic parameters a for hydrolysis of β-lactam substrates by OXA-405, OXA-163,
and OXA-48 β-lactamases.
Km (µM) a kcat (s−1) kcat/Km (mM−1 s−1)
Substrate OXA-405 OXA-163 OXA-48 OXA-405 OXA-163 OXA-48 OXA-405 OXA-163 OXA-48
Benzylpenicillin 18 13 ND b 12 23 ND 667 1800 ND
Ampicillin 212 315 395 29 23 955 137 70 2400
Oxacillin 69 90 95 19 34 130 275 370 1400
Temocillin NH c NH 45 NH NH 0.3 ND ND 6.6
Cephalothin 18 10 195 8 3 44 444 300 225
Cefotaxime 369 45 >900 9.7 10 >9 26 230 10
Ceftazidime >1000 >1000 NH 0.7 8 NH 0.7 3 NH
Imipenem 532 520 13 0.1 0.03 4.8 0.2 0.06 370
Meropenem >2000 >2000 11 0.1 >0.1 0.07 0.09 0.03 6.2
Ertapenem 88 130 100 0.04 0.05 0.13 0.4 0.3 1.3
a: data are the mean of three independent experiments; standard deviations were within 10% of the mean; b: ND,
not determined; c: NH, no detectable hydrolysis was observed with 1 mM of purified enzyme and 500 µM of
substrate. Data for OXA-163 are from Oueslati et al. [9] and OXA-48 from Docquier et al. [16].
This leads to a decrease of 1850-fold in the catalytic efficiency of OXA-405 for imipenem in
comparison to that of OXA-48, while, for OXA-163, a 6166-fold decrease was observed. However, it
is noteworthy that the catalytic efficiencies of OXA-405 are higher for ertapenem and imipenem as
compared to meropenem. Although the reason for this cannot be known without further structural
data, it is possible that the smaller size of imipenem in comparison to meropenem and ertapenem
allows it to fit better into the active site of OXA-48, leading to a higher rate of turnover of imipenem by
OXA-48, which is then lost due to the active-site expansion that occurs in OXA-405, as described below.
In summary, the results confirm the ability of the OXA-48 active site to accommodate
carbapenem substrates, particularly imipenem, while it is unable to hydrolyze ceftazidime, a bulkier
oxyimino-cephalosporin. Our results confirm, that the four AA deletion in the β5–β6 loop observed in
OXA-405 is responsible for a drastic loss of carbapenemase activity, particularly for imipenem, and a gain
of cephalosporinase activity with the ability to hydrolyze cefotaxime and ceftazidime. The hydrolytic
properties of OXA-405 make it more similar to an Amber class A extended-spectrum β-lactamase.
Therefore, the 213-TRIE-217 alters the substrate specificity of OXA-405. This finding is consistent with
previously published kinetic data showing a significant increase in the level of ceftazidime hydrolysis
compared to that of OXA-48. Additionally, two other members of the OXA-48-like β-lactamases,
OXA-247 and OXA-163, which differ from OXA-48 by a four amino acid deletion, 214-RIEP-218 and
214-RIEP-217 deletion and S212D substitution, respectively, have significantly lowered activity toward
carbapenem substrates as compared to that of OXA-48 [16]. Determination of IC50 (Table 2) showed
that OXA-405, as OXA-163 and OXA-48, can be inhibited by clavulanic acid (6 µM), tazobactam
(1.8 µM), and NaCl (40 × 103 µM).
Table 2. Fifty percent inhibitory concentration (IC50) of clavulanic acid and tazobactam forβ-lactamases
OXA-405, OXA-163, and OXA-48 a.
Inhibitor
IC50 (µM)
OXA-405 OXA-163 OXA-48
Clavulanic acid 6 13.4 28.5
Tazobactam 1.8 0.75 20
NaCl 40 × 103 97 × 103 35 × 103
Note: a data are the mean of three independent experiments; standard deviations were within 10% of the mean.
Data for OXA-163 from Stojanoski et al. [25].
In a general way, OXA-405 and OXA-163 have similar catalytic efficiency values for penicillin,
which are lower than those of OXA-48. Concerning cephalosporins, the three enzymes have nearly the
same catalytic efficiency for cephalothin, however, there is a difference for the hydrolysis of cefotaxime:
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value of OXA-405 (26 mM−1 s−1) is two-fold higher than OXA-48 (10 mM−1 s−1) but nine-fold lower
than that of OXA-163 (230 mM−1 s−1). The kcat/Km values for ceftazidime of OXA-405 (0.7 mM−1 s−1)
and OXA-163 (1.3 mM−1 s−1) are low, but significant to confer ceftazidime resistance in bacteria
expressing these enzymes, which is not the case for OXA-48. The fact that OXA-163 hydrolyses better
cefotaxime and ceftazidime as compared to OXA-405 is likely related to the two-point mutations
between these two enzymes.
3.2. X-Ray Crystallography
The crystal structure of OXA-405 refined at 2.26 Å presents the typical class D fold with an
α-helical region and a mixed α-helix/β-sheet region, with 96% of all residues inside the favored regions
of the Ramachandran plot, 4% in the allowed regions, and no outliers (Table 3).
Table 3. X-ray data collection and refinement statistics.
OXA-405
Protein Data Bank code 5FDH
wavelength (Å) 1.54187
Space group P43212
Asymmetric unit 1 dimer
Unit cell (Å)
A 90.40
B 90.40
C 172.63
α (deg) 90.0
β (deg) 90.0
γ (deg) 90.0
Resolution (Å) 13.12–2.26
Observed reflections 35,642 (4116) a
Unique reflections 10,205 (1346)
Completeness (%) 98.0 (90.3)
I/σ (I) 18.9 (4.6)
Rsym (%) 9.7 (46.8)
Rcryst (%) 17.5
Rfree (%) 21.3
no. of nonhydrogen atoms 4482
Protein 3952
heterogen 530
Waters 434
no. of protein residues 484
no. of ligands 8 SO4, 3 GOL
Root mean square deviation
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Table 3. Cont.
OXA-405
Bond lengths (Å) 0.010
Bond angles (deg) 1.10
Ramachandran
favored (%) 96
outliers (%) 0
Mean B value (Å2)
Protein 38.2 (chain A), 39.1 (chain B)
Solvent 46.1 (SO4) 55.2 (GOL), 45.9 (HOH)
a Numbers in parentheses represent values in the highest resolution shell: 2.26–2.40 Å (OXA-405).
The asymmetric unit contains two protein chains, A and B, modeled with 246 residues each.
The OXA-405 structure has a Cα RMSD of 0.52 Å on 236 residues compared to the OXA-48 structure
(PDB code 3HBR [16]) and 0.37 Å on 237 residues compared to OXA-163 (PDB code 4S2L [25]). The
conformations of residues from active sites are very similar (Figure 2A), and the only difference between
these three structures is the shorter β5–β6 loop in OXA-405 and OXA-163, due to the four-residue
deletion in this loop (Figure 2A), which induces important changes in the corresponding active sites
(Figure 2B). Clear electron density is observed for both backbones and side chains, including the active
site and the β5–β6 loop, with the exception of side chains of Lys218 (OXA-48 numbering) from the
β5–β6 loop (Figure 2C) and of Met22 (not shown).
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3.3. Structural Analysis of Covalent Protein-Ligand Complexes
A molecular modelling study was performed to identify the structural determinants that
could explain the differences between the hydrolytic profiles of OXA-405 and OXA-48. Covalent
docking calculations were performed with β-lactam antibiotics belonging to the penicillin (oxacillin),
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cephalosporin (cefotaxime, ceftazidime, and cephalothin), and carbapenem (ertapenem, imipenem,
and meropenem) families into the active site of OXA-405 (Figure 3).
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Figure 3. Covalent docking poses of oxacillin ((A), blue sticks), cefotaxime ((B), cyan sticks), ceftazidime
((C), pink sticks), cephalotin ((D), green sticks), ertapenem ((E), orange sticks), imipenem ((F), red
sticks) and meropenem ((G), yellow sticks), in the active site of OXA-405 (blue). Superposed OXA-163
(orange) and OXA-48 (magenta) are also shown for comparison. Key residues of the active sites are
represented as sticks and labelled using the OXA-48 numbering.
The binding mode of oxacillin is not influenced by the four-residues’ deletion in the β5–β6 loop
due to the relatively small size of the R2 substituent in the penicillin family (Figure 3A), which is in
agreement with similar Km values determined for OXA-405 and OXA-48 (Table 1). In contrast, the
R2 substituent of cephalosporins has unfavorable steric clashes with Arg214 in OXA-48 that are not
observed in OXA-405, where this residue is absent and the β5–β6 loop is shorter (Figure 3B–D). These
structural differences explain the systematically lower Km values of cephalosporins in the complex
with OXA-405 compared with those of OXA-48 (Table 1). On the other hand, the R2 substituent in
carbapenems is quite small compared to other β-lactams, and, in this case, the protein-ligand complexes
obtained by covalent docking (Figure 3E–G) cannot fully explain the higher Km values determined
with imipenem and meropenem, but not with ertapenem, in the complex with OXA-405 as compared
with OXA-48 (Table 1). These differences would likely come from contrasting levels of flexibility of the
β5–β6 loop in OXA-405 and OXA-48, due to the absence in the former case of the stabilizing interaction
between Arg214 (which is part of the four-residues deleted in the β5–β6 loop) and Asp159 from the
Ω loop.
3.4. Molecular Dynamics and Water Network Analysis
Molecular dynamics (MD) simulations of OXA-405 and OXA-48 dimers (50 ns each) that were
carried out by using Gromacs [21], with the OPLS-AA force field [22], confirmed the stability of these
systems (RMSD values of 2 Å or less for the entire length of the simulation) and constituted the input
data for the water network analysis, using the HOP software [23]. The stabilized water molecules
identified in this way on the protein surfaces of OXA-405 and OXA-48 are shown in Figure 4.
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Figure 4. Crystallographic water molecules (red) and stabilized water molecules computed with HOP
(blue) represented on the surfaces of OXA-405 ((A), brown) and OXA-48 ((B), magenta). Ser70 and
β5-β6 loop are colored in green and cyan, respectively.
These stabilized waters are more numerous than the crystallographic waters determined for
these two proteins, highlighting the superiority of the in-silico approach, which is not dependent
on the crystal structure resolution and takes into account the protein flexibility. In some cases, the
positions of waters determined using these two approaches were quite similar, emphasizing the
convergence of these two methods and the possible use of MD simulations to improve the refinement
of crystallographic structures [26].
4. Discus ion
OXA-48-producing Enterobacteriaceae are now endemic in the Mid le East, North Africa, and
India [7]. Since its first description, many variants have been identified [8]. Thre of them are
interesting—OXA-405, OXA-163 [10], and OXA-247 [12]—because they have a significant activity
toward expande -spectrum cephalosp rins but a very weak activity oward carbapenems. In this study,
we characterized the biochemical and structural properties of OXA-405, which has a four amino-acid
deletion 213-TRIE-217 compared to OXA-48. The steady-state kinetics of OXA-405 revealed that the
deletion conferred a decrease of the catalytic efficiency for carbapenems, particularly imipenem (with a
decrease of 1850-fold), but gains the ability to hydrolyze ceftazidime as compared to OXA-48. This
data show that the 213-TRIE-217 deletion alter the substrate specificity of the enzyme. This finding
is in agreement with previously published kinetics data of OXA-163, which has approximatively
the same deletion 214-RIEP-217, plus a substitution S212D [9]. Additionally, another member of the
OXA-48-like β-lactamases, OXA-247 [12,27], which differs from OXA-48 by another four amino-acid
deletion 214-RIEP-218, has significantly lowered activity toward carbapenem substrates as compared
to OXA-48. The IC50 values show that OXA-405, similarly to OXA-163, is susceptible to the inhibition
by class A inhibitors (tazobactam and clavulanic acid).
The crystal structure of OXA-405 showed that the 213-TRIE-217 deletion did not modify the overall
structure of the protein (Figure 2A) but resulted in an important decrease of the size of the β5–β6
loop, with important consequences on the overall shape of the binding site (Figure 2B). The Lys218 is
flexible, as shown by the reduced electron density observed on this side chain (Figure 2C). The covalent
docking calculations showed that Arg214 plays a key role in defining the hydrolysis profile. In OXA-48,
this residue blocks the binding of cephalosporins through unfavored steric clashes with their bulky R2
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substituents, whereas the carbapenems are accommodated into a specific conformation of the active
site stabilized by the ionic interaction between Arg214 and Asp159 [27]. OXA-405 features a more open
conformation of the active site due to the absence of Arg214 and its stabilizing interaction with Asp159,
as well as the smaller size of the β5–β6 loop. This leads to an increased affinity for cephalosporins and
a decreased stabilization of carbapenems in the active site, thus explaining the important differences in
affinity for these substrates observed between OXA-48 and OXA-405. Overall, all these observations
may constitute the basis for the development of efficient new inhibitors targeting all OXA-48-like
β-lactamases, and even the false carbapenemases like OXA-163, OXA-247, and OXA-405.
5. Conclusions
OXA-405 is a peculiar OXA-48-like enzyme, as it has lost carbapenem activities and gained
expanded-spectrum cephalosporin hydrolytic activity subsequent to a 4 amino-acid (AA) deletion in
the β5–β6 loop. Kinetic parameters confirmed that OXA-405 behaves more like an ESBL ß-lactamase,
rather than a carbapenemase. Molecular modeling techniques and 3D structure determination show
that the overall dimeric structure of OXA-405 is very similar to that of OXA-48, except for the β5–β6
loop, which is shorter for OXA-405, suggesting that the length of the β5–β6 loop is critical for substrate
specificity. Covalent docking with selected substrates and molecular dynamics simulations evidenced
the structural changes induced by substrate binding, as well as the distribution of water molecules in
the active site and their role in substrate hydrolysis. All this data may represent the structural basis
for the design of new and efficient class D inhibitors. Our findings provide a molecular basis for
the hydrolysis of ceftazidime by OXA-405 and, more broadly, illustrate further how minor sequence
changes can profoundly alter the structure of the active site and thereby affect the substrate profile of
an enzyme. Furthermore, our results should allow us to better understand the potential of class D
carbapenemases, to extend their spectrum, and thus evaluate the potential threat to public health.
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